Gilead Sciences, Inc. (BIT:1GILD)

Gilead Sciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	123,152	111,192	91,322	100,753	80,087	59,702
Market Cap Growth	52.88%	21.76%	-9.36%	25.80%	34.14%	-18.50%
Enterprise Value	136,918	127,099	105,598	117,295	97,655	61,567
Last Close Price	98.57	88.31	69.94	73.18	57.02	39.02
PE Ratio	22.31	239.83	17.82	23.45	14.63	593.74
PS Ratio	4.63	4.00	3.72	3.95	3.34	2.96
PB Ratio	6.98	5.98	4.44	5.08	4.32	4.01
P/FCF Ratio	13.52	11.17	13.60	12.91	8.43	9.71
P/OCF Ratio	12.84	10.63	12.61	11.87	8.00	8.94
EV/Sales Ratio	5.59	4.58	4.31	4.60	4.07	3.05
EV/EBITDA Ratio	11.57	9.78	9.75	9.59	7.94	6.05
EV/EBIT Ratio	14.67	12.31	12.58	11.42	9.31	6.87
EV/FCF Ratio	15.03	12.77	15.73	15.02	10.28	10.02
Debt / Equity Ratio	1.31	1.42	1.13	1.22	1.30	1.76
Debt / EBITDA Ratio	1.80	2.01	2.11	1.95	1.93	2.55
Debt / FCF Ratio	2.54	2.65	3.46	3.09	2.53	4.27
Asset Turnover	0.51	0.48	0.43	0.42	0.40	0.38
Inventory Turnover	3.46	3.58	3.66	3.62	3.35	2.83
Quick Ratio	1.06	1.33	1.15	1.03	1.02	1.20
Current Ratio	1.37	1.60	1.43	1.29	1.27	1.40
Return on Equity (ROE)	32.66%	2.29%	25.54%	21.60%	31.57%	0.44%
Return on Assets (ROA)	12.14%	11.03%	9.25%	10.46%	10.94%	10.54%
Return on Capital (ROIC)	15.79%	14.07%	12.15%	14.38%	15.11%	13.94%
Return on Capital Employed (ROCE)	24.80%	22.70%	18.20%	21.10%	21.20%	19.20%
Earnings Yield	4.48%	0.42%	5.61%	4.26%	6.83%	0.17%
FCF Yield	7.40%	8.95%	7.35%	7.75%	11.86%	10.29%
Dividend Yield	2.25%	3.37%	3.88%	3.73%	4.38%	5.70%
Payout Ratio	66.02%	816.25%	67.24%	80.77%	57.91%	2804.07%
Buyback Yield / Dilution	-0.28%	0.24%	0.32%	0.08%	0.08%	1.10%
Total Shareholder Return	1.97%	3.61%	4.20%	3.81%	4.46%	6.79%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.